Tag: Cipla
Molnupiravir newest antiviral for Covid-19
Molnupiravir, the newest antiviral on the market to treat Covid-19, had been submitted to the Indian drug regulatory authorities for approval. Thirteen were given...
Cipla acquires stake in Clean Max Auriga Power
Cipla announced that it has acquired up to 33% of a partnership interest in Clean Max Auriga Power. This agreement is in line with...
Cipla launches Spirofy to treat chronic obstructive pulmonary disorder and asthma
Cipla announced the launch of Spirofy, India’s first pneumotach-based portable, wireless spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive...
The modernization of the Perfect Containers Group
Founded almost 40 years ago, the Perfect Containers Group is a family-owned and managed business, headquartered in Mumbai with seven manufacturing plants for tubes...
Eli Lilly & Cipla enter into a strategic partnership in India
Eli Lilly and Company (India) (hereinafter referred as “Lilly”), headquartered in Gurgaon, is a wholly-owned subsidiary of Eli Lilly and Company, a global biopharmaceutical...
Merck’s Molnupiravir tests positive for Covid-19 treatment in India
Pharmaceutical giant Merck recently reported positive results on clinical trials for its antiviral medication Molnupiravir against the novel Coronavirus. According to the clinical trial...
Cipla & Kemwell Biopharma announce joint venture
Cipla and Kemwell Biopharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the execution of a joint venture agreement to develop, manufacture...
Cipla, Dr. Reddy’s, Emcure, Sun Pharma & Torrent to collaborate for...
On 29 June 2021, five Indian Indian pharma companies announced their collaboration for a clinical trial of the anti-viral drug Molnupiravir. Cipla, Dr Reddy’s...
Rubicon Research acquires Cipla’s Meditab Specialities Satara plant
On 8 July, Rubicon Research announced the acquisition of Cipla's Meditab Specialties plant in Satara in Maharashtra. It is expected that the closing of...
Cipla launches ‘ELIFast’ (IgG ELISA test) for Covid-19 antibody detection
Mumbai-based Cipla announced the commercialization of antibody detection kits for Covid-19 in India. In partnership with KARWA under the technology transfer from the Indian...